Name: Cytokines at the Crossroads of Health and Disease (en Inglés)
SKU: 65905374
Price: 1322.83 MXN
Availability: InStock
Author: El-Banna, Mona
ISBN: 9786209027437

portada Cytokines at the Crossroads of Health and Disease (en Inglés)

Cytokines at the Crossroads of Health and Disease (en Inglés)

Formato

Libro Físico

Editorial

LAP Lambert Academic Publishing

Autor

El-Banna, Mona

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.6 cm

ISBN13

9786209027437

Cytokines at the Crossroads of Health and Disease (en Inglés)

El-Banna, Mona (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 2,405.14$ 1,322.83

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 1,322.83

¡Envío Gratis! Llega entre el 19 Nov y el 27 Nov a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Cytokines at the Crossroads of Health and Disease (en Inglés)"

Cytokines have emerged as pivotal regulators of communication between immune and non-immune cells, orchestrating the delicate balance between host defense, inflammation, and tissue homeostasis. Their pleiotropic effects extend far beyond immunology, influencing hematopoiesis, neuroendocrine regulation, tissue repair, and even developmental biology. This book provides a comprehensive exploration of cytokines, the small but powerful proteins that orchestrate immune regulation, inflammation, and intercellular communication. It examines the biology, classification, and mechanisms of cytokines, including interleukins, interferons, tumor necrosis factors, chemokines, and growth factors. Special emphasis is placed on their roles in health and disease, such as infection, autoimmune disorders, allergy, cancer, and tissue repair. By integrating molecular insights with clinical applications, the book bridges fundamental immunology with translational medicine. It also highlights therapeutic advances, including recombinant cytokines, monoclonal antibodies, fusion proteins, and cytokine inhibitors, underscoring their promise and limitations in clinical practice.